Jennison Associates’s Notable Labs, Ltd. Ordinary Shares NTBL Stock Holding History

Jennison Associates’s Portfolio NTBL Stock Details NTBL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-18,937	Closed	-$3.92M	–	757
2014 Q4	$3.92M	Buy	+18,937	New	+$4.09M	﹤0.01%	523

Other funds holding NTBL

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

CCA

Catalyst Capital Advisors Huntington, New York $6.03B AUM 24.5% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jennison Associates's NTBL Position: Q1 2015 in Review

Jennison Associates sold out of Notable Labs, Ltd. Ordinary Shares (NTBL) in Q1 2015, closing a stake of 18,937 shares — an estimated $3.92M sold.

Jennison Associates first reported a position in NTBL in Q4 2014 and held it in 1 quarter. The position peaked at $3.92M in Q4 2014. 8 funds tracked by Wall St. Rank hold NTBL as of Q1 2015.

Jennison Associates reported no remaining Notable Labs, Ltd. Ordinary Shares position as of Q1 2015 after selling out during the quarter.
Jennison Associates sold 18,937 Notable Labs, Ltd. Ordinary Shares shares in Q1 2015, an estimated $3.92M.
Jennison Associates first reported a position in Notable Labs, Ltd. Ordinary Shares in Q4 2014 and held it in 1 quarter.
Jennison Associates's Notable Labs, Ltd. Ordinary Shares position peaked at $3.92M in Q4 2014.
8 funds tracked by Wall St. Rank held Notable Labs, Ltd. Ordinary Shares as of Q1 2015.

Based on Jennison Associates's 13F filing for Q1 2015, filed 4 May 2015.